Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed at Sun Yat-sen ...
It's been a roller coaster ride for the drug ever since it was granted accelerated approval in 2020 for the treatment of ...
Belantamab mafodotin provides a community-friendly BCMA-directed therapy option for relapsed/refractory myeloma, says Hearn ...
Moderna Inc. (NASDAQ:MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, ...
News-Medical.Net on MSN
Breakthrough combo therapy lowers death risk in recurrent prostate cancer
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%.
Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our ...
Producers face decisions that could mean the difference between manageable losses and significant mortalities.
The Ministry of Agriculture, Food and Rural Affairs said on the 21st that an H5 avian influenza (AI) antigen was detected at a small-scale other poultry farm in Gwangju. During the special quarantine ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
Belantamab mafodotin, a BCMA-targeting ADC, is approved for relapsed/refractory multiple myeloma after two prior therapies, ...
Even for a newly minted Nobel laureate, downtime is hard to find. | Even for a newly minted Nobel laureate, downtime is hard ...
Chronic malaria exposure has been proposed to modulate immune function, but its long-term effects on antibody-mediated responses to unrelated pathogens remain poorly defined. Whether these effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results